University of Maryland BaltImore Life Science Discovery (UM-BILD) Accelerator

项目摘要/摘要 马里兰大学巴尔的摩生命科学发现加速器(UM-Bild)的目标是创建一个 作为开发的新的NIH研究评估和商业化中心(REACH)计划 在西巴尔的摩和大巴尔的摩建立生命科学经济的引擎，并培训最多的 美国多样化的生物医学和创业劳动力。代表不足的少数族裔(URM)组成 34%的人口，城市管理机构只有15%的博士毕业生和4%的终身教员职位 医学院。风投支持的创始人之间的多样性更是少之又少。这是在有证据表明 提高员工多样性可提高工作效率、财务业绩和员工满意度。嗯-图片 将与马里兰大学巴尔的摩大学(UMB)、马里兰大学马里兰州学院 医学(UMSOM)，马里兰大学巴尔的摩县分校(UMBC)(少数民族服务机构)，大学 马里兰学院公园，摩根州立大学(历史上的黑人学院/大学(HBCU))，Blackbird 实验室(1亿美元生命科学研究所/孵化器)和马里兰州创新倡议(MII)。整个巴尔的摩 大学和生命科学创新者将有机会获得中心的专业知识、资源和网络。嗯-图片 将直接满足增加生物医学和创业员工多样性的需求，利用现有的、 UMSOM和UMBC的成功倡议。UM-Bild将促进全球生命科学产业的增长 人口结构多样化(28%非裔美国人和7%西班牙裔)巴尔的摩地区。嗯-《图片报》将拥抱 现有的合作伙伴方案努力，以增加生物医学工作人员的多样性；以及直接参与 与HBCU和少数族裔服务机构合作。UM-Bild将征集、鉴定和发展早期生命科学 涵盖所有技术类型的平台和项目。UM-Bild将有三个具体目标：Aim 1：每年为11个早期技术项目团队提供种子投资和开发资源 通过伙伴机构和工业和信息化部提供500万美元的非联邦配对基金。技术将获得 里程碑担保投资高达200,000美元，并获得UMB独特的生物医学开发设施 和UMBC作为专门的孵化器。目标2：培养多样化的生物医学和创新劳动力 精英科学家和创新者。我们将提供专门的创业、项目管理和业务 开发课程将建立在UMB和UMB正在进行的生物医学劳动力多样化计划的基础上 UMBC，以及整个巴尔的摩地区，以允许新培训的生命科学的独特队列 企业家，其中许多人来自URM背景。目标3：创建准备申请联邦政府的新公司 SBIR/STTR奖，并筹集私人资本，以发展巴尔的摩的生命科学经济。Um-Bild将提供 公司组建方面的服务，获得联邦创新拨款方面的培训；与寻求 早期生命科学机会(见支持函)；以及巴尔的摩生物公园的补贴空间。

PROJECT SUMMARY/ABSTRACT The goal of the University of Maryland BaltImore Life Science Discovery Accelerator (UM-BILD) is to create a new NIH Research Evaluation and Commercialization Hub (REACH) program that serves as a development engine to build the life science economy in West Baltimore and Greater Baltimore and to train one of the most diverse biomedical and entrepreneurial workforces in the US. Underrepresented minorities (URM) making up 34% of the population, URMs comprise only 15% of PhD graduates and 4% of tenured faculty positions in medical schools. Diversity amongst venture-backed founders is even less. This is in the face of evidence that increased workforce diversity increases productivity, financial performance, and employee satisfaction. UM-BILD will be formed from a partnership with University of Maryland Baltimore (UMB), University Maryland School of Medicine (UMSOM), University of Maryland Baltimore County (UMBC) (a Minority Serving Institution), University of Maryland College Park, Morgan State University (a Historically Black College/University (HBCU)), Blackbird Laboratories ($100MIL life science institute/incubator), and the Maryland Innovation Initiative (MII). All Baltimore universities and life science innovators will have access to hub expertise, resources, and networking. UM-BILD will directly address the need for increased biomedical and startup workforce diversity leveraging existing, successful initiatives at UMSOM and UMBC. UM-BILD will foster life science industry growth of the demographically diverse (28% African American and 7% Hispanic) Baltimore Region. UM-BILD will embrace existing partner programmatic efforts to increase biomedical workforce diversity; as well as direct engagement with HBCU’s and Minority serving institutions. UM-BILD will solicit, identify, and develop early-stage life science platforms and projects over the entire spectrum of technology types. UM-BILD will have three specific aims: Aim 1: Provide seed investment and development resources for 11 early-stage technology projects teams per year enhanced by a $5 million non-federal match funds through partner institutions and MII. Technologies will receive milestone gated investments of up to $200,000 and access to unique biomedical development facilities at UMB and UMBC to serve as a dedicated incubator. Aim 2: Train a diverse biomedical and innovation workforce from elite scientists and innovators. We will offer a dedicated entrepreneurial, project management, and business development curriculum that will build upon on-going biomedical workforce diversification programs at UMB and UMBC, and the Baltimore region in general, to allow for a unique cohort of newly trained life science entrepreneurs, many from URM backgrounds. Aim 3: Create new companies ready to apply for federal SBIR/STTR awards and raise private capital to grow the life science economy in Baltimore. UM-BILD will provide services in company formation, training in obtaining federal innovation grants; connections to investors seeking early-stage life science opportunities (see letters of support); and subsidized space in Baltimore Bioparks.